A detailed history of Toroso Investments, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Toroso Investments, LLC holds 11,681 shares of VRTX stock, worth $5.47 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
11,681
Previous 11,681 -0.0%
Holding current value
$5.47 Million
Previous $5.43 Million -0.0%
% of portfolio
0.07%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $139,380 - $153,251
-303 Reduced 2.53%
11,681 $5.43 Million
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $1.22 Million - $1.5 Million
-3,098 Reduced 20.54%
11,984 $5.62 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $1.65 Million - $1.8 Million
4,036 Added 36.54%
15,082 $6.3 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $213,689 - $255,853
-623 Reduced 5.34%
11,046 $4.49 Million
Q3 2023

Nov 15, 2023

SELL
$338.18 - $362.46 $1.1 Million - $1.18 Million
-3,260 Reduced 21.84%
11,669 $4.06 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $734,170 - $821,709
-2,335 Reduced 13.53%
14,929 $5.25 Million
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $1.94 Million - $2.22 Million
-6,867 Reduced 28.46%
17,264 $5.44 Million
Q4 2022

Feb 15, 2023

SELL
$285.76 - $321.48 $256,612 - $288,689
-898 Reduced 3.59%
24,131 $6.97 Million
Q3 2022

Nov 23, 2022

BUY
$273.83 - $305.53 $2.27 Million - $2.53 Million
8,281 Added 49.44%
25,029 $7.25 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $413,999 - $515,473
-1,762 Reduced 9.52%
16,748 $4.72 Million
Q1 2022

May 20, 2022

BUY
$221.42 - $260.97 $4.1 Million - $4.83 Million
18,510 New
18,510 $4.83 Million
Q4 2021

Feb 16, 2022

SELL
$177.01 - $223.45 $1.49 Million - $1.88 Million
-8,410 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $407,764 - $456,321
2,248 Added 36.48%
8,410 $1.53 Million
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $625,654 - $737,810
3,337 Added 118.12%
6,162 $1.24 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $159,405 - $185,808
770 Added 37.47%
2,825 $607,000
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $125,655 - $167,586
607 Added 41.92%
2,055 $486,000
Q3 2020

Nov 16, 2020

BUY
$255.65 - $303.1 $40,904 - $48,496
160 Added 12.42%
1,448 $394,000
Q2 2020

Aug 17, 2020

SELL
$225.48 - $295.8 $114,769 - $150,562
-509 Reduced 28.32%
1,288 $374,000
Q1 2020

May 08, 2020

BUY
$199.77 - $247.81 $98,286 - $121,922
492 Added 37.7%
1,797 $428,000
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $68,351 - $91,803
-410 Reduced 23.91%
1,305 $286,000
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $285,084 - $320,859
1,715 New
1,715 $291,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.